Renal processing of glucose in well and sick neonates

M G Coulthard1, E N Hey

  • 1Department of Child Health Royal Victoria Infirmary Newcastle upon Tyne NE1 4LP.

Insights

Neonates

Area of Science:

  • Neonatal physiology
  • Renal function in infants

Background:

  • Understanding renal glucose handling is crucial for managing sick neonates.
  • Limited data exists on glucose excretion in neonates under varying clinical conditions.

Purpose of the Study:

  • To quantify renal glucose processing in neonates.
  • To compare glucose excretion in sick versus well neonates.

Main Methods:

  • Measured glomerular filtration rate (GFR) and renal glucose, sodium, and water processing.
  • Utilized prolonged inulin infusion in 47 infants (26-40 weeks gestation, 1-13 days old).

Main Results:

  • GFR increased post-ventilation; clinical instability did not affect GFR.
  • Fractional glucose excretion was generally low but higher in ventilated neonates.
  • Ventilation, clinical status, and glycosuria did not impact water and sodium balance.

Conclusions:

  • Neonates are unlikely to develop osmotic diuresis from glycosuria below 12 mmol/l blood glucose.
  • Low GFR, high fluid intake, and urine flow protect neonates from osmotic diuresis.
Abstract

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...